Automated Production of Human Induced Pluripotent Stem Cell-Derived Cortical and Dopaminergic Neurons with Integrated Live-Cell Monitoring.


Journal

Journal of visualized experiments : JoVE
ISSN: 1940-087X
Titre abrégé: J Vis Exp
Pays: United States
ID NLM: 101313252

Informations de publication

Date de publication:
06 08 2020
Historique:
entrez: 25 8 2020
pubmed: 25 8 2020
medline: 21 11 2020
Statut: epublish

Résumé

Manual culture and differentiation protocols for human induced pluripotent stem cells (hiPSC) are difficult to standardize, show high variability and are prone to spontaneous differentiation into unwanted cell types. The methods are labor-intensive and are not easily amenable to large-scale experiments. To overcome these limitations, we developed an automated cell culture system coupled to a high-throughput imaging system and implemented protocols for maintaining multiple hiPSC lines in parallel and neuronal differentiation. We describe the automation of a short-term differentiation protocol using Neurogenin-2 (NGN2) over-expression to produce hiPSC-derived cortical neurons within 6‒8 days, and the implementation of a long-term differentiation protocol to generate hiPSC-derived midbrain dopaminergic (mDA) neurons within 65 days. Also, we applied the NGN2 approach to a small molecule-derived neural precursor cells (smNPC) transduced with GFP lentivirus and established a live-cell automated neurite outgrowth assay. We present an automated system with protocols suitable for routine hiPSC culture and differentiation into cortical and dopaminergic neurons. Our platform is suitable for long term hands-free culture and high-content/high-throughput hiPSC-based compound, RNAi and CRISPR/Cas9 screenings to identify novel disease mechanisms and drug targets.

Identifiants

pubmed: 32831313
doi: 10.3791/61525
doi:

Substances chimiques

Carbon Dioxide 142M471B3J

Types de publication

Journal Article Research Support, Non-U.S. Gov't Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Ashutosh Dhingra (A)

Genome Biology of Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE); ashutosh.dhingra@dzne.de.

Joachim Täger (J)

Genome Biology of Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE).

Elisangela Bressan (E)

Genome Biology of Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE).

Salvador Rodriguez-Nieto (S)

Genome Biology of Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE).

Manmeet-Sakshi Bedi (MS)

Genome Biology of Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE).

Stefanie Bröer (S)

Genome Biology of Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE).

Eldem Sadikoglou (E)

Genome Biology of Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE).

Noémia Fernandes (N)

Applied Genomics for Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE).

Melissa Castillo-Lizardo (M)

Genome Biology of Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE).

Patrizia Rizzu (P)

Applied Genomics for Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE).

Peter Heutink (P)

Genome Biology of Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE); Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH